In vivo animal studies with gadolinium (III) texaphyrin as a radiation enhancer
- 1 November 1999
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 45 (4) , 981-989
- https://doi.org/10.1016/s0360-3016(99)00274-6
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- One-Electron Reduction and Oxidation Studies of the Radiation Sensitizer Gadolinium(III) Texaphyrin (PCI-0120) and Other Water Soluble MetallotexaphyrinsThe Journal of Physical Chemistry A, 1999
- Lutetium Texaphyrin (PCI‐0123): A Near‐Infrared, Water‐Soluble PhotosensitizerPhotochemistry and Photobiology, 1996
- Porphyrins and Metalloporphyrins: Potential Hypoxic AgentsMetal-Based Drugs, 1996
- Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death.The Journal of Experimental Medicine, 1995
- In vivo radiation sensitivity of glioblastoma multiformeInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Texaphyrins: Synthesis and ApplicationsAccounts of Chemical Research, 1994
- Gadolinium(III) texaphyrin: a novel MRI contrast agentJournal of the American Chemical Society, 1993
- Synthesis and structural characterization of lanthanide(III) texaphyrinsInorganic Chemistry, 1993
- Radiation therapy oncology group clinical trials with misonidazoleCancer, 1981
- Initial United States clinical and pharmacologic evaluation of misonidazole (Ro-07-0582), an hypoxic cell radiosensitizerInternational Journal of Radiation Oncology*Biology*Physics, 1979